JPRN-UMIN000003695
Completed
未知
Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study - Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study (ACHIEVE ONE)
Ajinomoto Pharmaceuticals Co., LTD.0 sites3,000 target enrollmentJune 4, 2010
ConditionsEssential Hypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Essential Hypertension
- Sponsor
- Ajinomoto Pharmaceuticals Co., LTD.
- Enrollment
- 3000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Pregnant or possibly pregnant patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Home Blood Pressure Monitoring and blood pressure (BP) controlISRCTN25105161Heart and Stroke Foundation of Ontario (Canada)630
Completed
Not Applicable
Blood pressure monitoring in hypertensive antenatal womeHealth Condition 1: - Health Condition 2: O133- Gestational [pregnancy-induced] hypertension without significant proteinuria, third trimesterCTRI/2022/09/045801Department of obstetrics and gynaecology LHMC170
Completed
Not Applicable
The importance of home blood pressure in patients with diabetes.diabetes mellitusJPRN-UMIN000018581Kyoto Prefectural University of Medicine, Graduate School of Medical Science50
Recruiting
Not Applicable
Implementation of continuous home blood pressure measurement and monitoring of lifestyle in prospective cohort study participants in Tarumizu cityJPRN-UMIN000046279Department of Cardiovascular medicine and hypertension, Graduate school of medical and dental sciences, Kagoshima university600
Withdrawn
Phase 4
Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) StudyCardiovascular DiseaseVascular DiseaseHypertensionNCT00334724Kyoto University, Graduate School of Medicine